These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21466547)

  • 1. The experience of Flebogammadif® in primary immune thrombocytopenia.
    Julia A
    Clin Exp Immunol; 2011 Jun; 164 Suppl 2(Suppl 2):12-5. PubMed ID: 21466547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
    Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
    Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of a novel intravenous immunoglobulin preparation in adult chronic ITP.
    Colovic M; Dimitrijevic M; Sonnenburg C; Suvajdzic N; Donfrid M; Bogdanovic A
    Hematol J; 2003; 4(5):358-62. PubMed ID: 14502262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
    Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
    J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of Gammaplex® in idiopathic thrombocytopenic purpura (ClinicalTrials.gov--NCT00504075).
    Dash CH; Gillanders KR; Stratford Bobbitt ME; Gascoigne EW; Leach SJ
    PLoS One; 2014; 9(6):e96600. PubMed ID: 24892422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a new intravenous immunoglobulin (Panzyga
    Arbach O; Taumberger AB; Wietek S; Cervinek L; Salama A
    Transfus Med; 2019 Feb; 29(1):48-54. PubMed ID: 30687970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of intravenous immunoglobulin (Flebogamma
    Apte S; Navarro-Puerto J; Damodar S; Ramanan V; John J; Kato G; Ross C; Shah C; Torres M; Fu C'; Rucker K; Pinciaro P; Barrera G; Aragonés ME; Ayguasanosa J
    Immunotherapy; 2019 Feb; 11(2):81-89. PubMed ID: 30499734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy, tolerability, safety and pharmacokinetics of a nanofiltered intravenous immunoglobulin: studies in patients with immune thrombocytopenic purpura and primary immunodeficiencies.
    Wolf HH; Davies SV; Borte M; Caulier MT; Williams PE; Bernuth HV; Egner W; Sklenar I; Adams C; Späth P; Morell A; Andresen I
    Vox Sang; 2003 Jan; 84(1):45-53. PubMed ID: 12542733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a new intravenous immunoglobulin 10% formulation (octagam® 10%) in patients with immune thrombocytopenia.
    Robak T; Mainau C; Pyringer B; Chojnowski K; Warzocha K; Dmoszynska A; Straub J; Imbach P
    Hematology; 2010 Oct; 15(5):351-9. PubMed ID: 20863431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
    Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
    Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
    Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children.
    Ancona KG; Parker RI; Atlas MP; Prakash D
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):540-4. PubMed ID: 12368690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases.
    Zhou Z; Qiao Z; Li H; Luo N; Zhang X; Xue F; Yang R
    Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura.
    van der Meer JW; van Beem RT; Robak T; Deptala A; Strengers PF
    Vox Sang; 2011 Aug; 101(2):138-46. PubMed ID: 21749402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.
    Fujisawa K; Iyori H; Ohkawa H; Konishi S; Bessho F; Shirahata A; Miyazaki S; Akatsuka J;
    Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IVIg treatment increases thrombin activation of platelets and thrombin generation in paediatric patients with immune thrombocytopenia.
    Schmugge M; Franzoso FD; Winkler J; Kroiss S; Seiler M; Speer O; Rand ML
    Br J Haematol; 2023 Jun; 201(6):1209-1219. PubMed ID: 36861460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.